[Summary text]
Data obtained from:
Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for fibromyalgia in adults. Cochrane Database of Systematic Reviews 2015, Issue 7, Art. No.: CD011824. doi: 10.1002/14651858.CD011824
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
and
Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for fibromyalgia in adults. Cochrane Database of Systematic Reviews 2015, Issue 7, Art. No.: CD011824. doi: 10.1002/14651858.CD011824
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
and
Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for fibromyalgia in adults. Cochrane Database of Systematic Reviews 2015, Issue 7, Art. No.: CD011824. doi: 10.1002/14651858.CD011824
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
and
Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for fibromyalgia in adults. Cochrane Database of Systematic Reviews 2015, Issue 7, Art. No.: CD011824. doi: 10.1002/14651858.CD011824
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for fibromyalgia in adults. Cochrane Database of Systematic Reviews 2015, Issue 7, Art. No.: CD011824. doi: 10.1002/14651858.CD011824
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
and
Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for fibromyalgia in adults. Cochrane Database of Systematic Reviews 2015, Issue 7, Art. No.: CD011824. doi: 10.1002/14651858.CD011824
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
and
Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for fibromyalgia in adults. Cochrane Database of Systematic Reviews 2015, Issue 7, Art. No.: CD011824. doi: 10.1002/14651858.CD011824
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
and
Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for fibromyalgia in adults. Cochrane Database of Systematic Reviews 2015, Issue 7, Art. No.: CD011824. doi: 10.1002/14651858.CD011824
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
and
Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for fibromyalgia in adults. Cochrane Database of Systematic Reviews 2015, Issue 7, Art. No.: CD011824. doi: 10.1002/14651858.CD011824
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Reference: Moore et al., 2015
Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Reference: Moore et al., 2015
Performance bias due to knowledge of the allocated interventions by participants and personnel during the study
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Reference: Moore et al., 2015
Detection bias due to knowledge of the allocated interventions by outcome assessors
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Reference: Moore et al., 2015
Attrition bias due to amount, nature or handling of incomplete outcome data
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Reference: Moore et al., 2015
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Reference: Moore et al., 2015
Reporting bias due to selective outcome reporting
Not addressed in Moore et al., 2015
Not addressed in Moore et al., 2015
Not addressed in Moore et al., 2015
Not addressed in Moore et al., 2015
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Not addressed in Moore et al., 2015
Not addressed in Moore et al., 2015
Not addressed in Moore et al., 2015
Not addressed in Moore et al., 2015
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Not addressed in Moore et al., 2015
Bias due to problems not covered elsewhere in the table
Moore et al., 2015 (Size)
Reference: Moore et al., 2015 (Size)
Reference: Moore et al., 2015 (Size)
Reference: Moore et al., 2015 (Size)
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Reference: Moore et al., 2015 (Size)
Reference: Moore et al., 2015 (Size)
Reference: Moore et al., 2015 (Size)
Reference: Moore et al., 2015 (Size)
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Data obtained from:
Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. [Article in German].
Schmerz.2012 Jun;26(3):297-310. doi: 10.1007/s00482-012-1172-2.
Reference: Moore et al., 2015 (Size)